11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle
Summary Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological ac...
Saved in:
| Published in | Clinical endocrinology (Oxford) Vol. 65; no. 6; pp. 800 - 805 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.12.2006
Blackwell |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0300-0664 1365-2265 |
| DOI | 10.1111/j.1365-2265.2006.02669.x |
Cover
| Abstract | Summary
Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1.
Design Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis.
Measurements (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3H cortisone to cortisol.
Results 11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔCT of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔCT of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔCT of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH (r = 0·67, P = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%).
Conclusions 11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo. |
|---|---|
| AbstractList | Summary
Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1.
Design Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis.
Measurements (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3H cortisone to cortisol.
Results 11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔCT of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔCT of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔCT of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH (r = 0·67, P = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%).
Conclusions 11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo. Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1. Design Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis. Measurements (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3 H cortisone to cortisol. Results 11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔC T of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔC T of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔC T of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH ( r = 0·67, P = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%). Conclusions 11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo . |
| Author | Obeyesekere, Varuni R. Jang, Christina Inder, Warrick J. Alford, Frank P. Dilley, Rodney J. |
| Author_xml | – sequence: 1 givenname: Christina surname: Jang fullname: Jang, Christina organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and – sequence: 2 givenname: Varuni R. surname: Obeyesekere fullname: Obeyesekere, Varuni R. organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and – sequence: 3 givenname: Rodney J. surname: Dilley fullname: Dilley, Rodney J. organization: Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia – sequence: 4 givenname: Frank P. surname: Alford fullname: Alford, Frank P. organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and – sequence: 5 givenname: Warrick J. surname: Inder fullname: Inder, Warrick J. organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18294333$$DView record in Pascal Francis |
| BookMark | eNqNkc9u1DAQxi1UJLYL7-ALxwQ7Tuz4ABJa-oeqLQcqcbRm7UnrrTdZ2Skkb9Nn6CPwADwTCVvtgQvMZazP_n1jfXNMjtquRUIoZzmf6t0m50JWWVHIKi8YkzkrpNT58IIsDhdHZMEEYxmTsnxFjlPaMMaqmqkF2XD-64mejy52w5h6jJ131OHdLNxiCwlpP-7w5yOnPlEcdhFTQkehdbOw9l3obr2FEEYKtvffkfqW3j1soaXpHgP2EOj2IdmAr8nLBkLCN899SW5OT25W59nll7PPq4-XmS201JmSJVOuRGANAiLophFizUu9dqoQoq6Rcy0njSmltGtcg1jDWlpuoRJSLMnbve0O0vSvJkJrfTK76LcQR8PrQpdiqiX5sH9nY5dSxMZY30Pvu7aP4IPhzMwBm42ZczRzjmYO2PwJ2AyTQf2XwWHGv9H3e_SHDzj-N2dWJ9fzaeKzPe-nlQ0HHuK9kUqoyny7PjPVhb76dHH61SjxG4_fp1Y |
| CODEN | CLECAP |
| CitedBy_id | crossref_primary_10_2337_db11_1345 crossref_primary_10_1002_path_4806 crossref_primary_10_1186_1868_7083_4_24 crossref_primary_10_1007_s11102_008_0098_2 crossref_primary_10_1016_j_mce_2010_12_004 crossref_primary_10_1016_j_mce_2013_03_003 crossref_primary_10_1210_jc_2006_2729 crossref_primary_10_1002_glia_21007 crossref_primary_10_1080_13813450701531219 crossref_primary_10_1002_dmrr_944 crossref_primary_10_1016_j_jsbmb_2008_06_015 crossref_primary_10_1371_journal_pone_0084057 crossref_primary_10_1210_en_2008_1618 crossref_primary_10_1007_s00125_014_3228_6 crossref_primary_10_1111_j_1365_2265_2009_03683_x crossref_primary_10_1016_j_mce_2009_09_024 crossref_primary_10_1016_j_steroids_2011_06_003 crossref_primary_10_1210_en_2010_0957 crossref_primary_10_1210_endrev_bnae008 crossref_primary_10_2337_db09_0525 crossref_primary_10_1016_j_jsbmb_2017_07_030 crossref_primary_10_1210_en_2007_0597 crossref_primary_10_1016_j_cbi_2017_02_018 |
| Cites_doi | 10.1210/jcem-73-2-326 10.1016/S0021-9258(18)55351-5 10.1111/j.1365-2362.2005.01552.x 10.1016/j.febslet.2004.06.065 10.2337/diacare.21.12.2191 10.1210/jc.87.3.1205 10.1016/S0140-6736(96)11222-8 10.1152/ajpendo.1995.268.3.E453 10.1007/BF03343855 10.1007/s00253-002-1191-5 10.1210/er.2003-0031 10.1677/jme.1.01718 10.1007/s001250051457 10.1172/JCI111938 10.1210/jc.83.5.1668 10.1002/mus.880030308 10.1111/j.1464-5491.2005.01566.x 10.2337/diabetes.50.6.1324 10.1210/jc.2002-030017 10.1074/jbc.M404159200 10.1007/s00125-004-1407-6 10.1016/0303-7207(94)90176-7 10.1210/en.142.4.1644 10.1136/bjsm.37.5.436 10.1210/endo.142.4.8114 10.1210/jc.86.5.2296 10.2337/diabetes.51.4.1066 |
| ContentType | Journal Article |
| Copyright | 2007 INIST-CNRS |
| Copyright_xml | – notice: 2007 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW |
| DOI | 10.1111/j.1365-2265.2006.02669.x |
| DatabaseName | Istex CrossRef Pascal-Francis |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-2265 |
| EndPage | 805 |
| ExternalDocumentID | 18294333 10_1111_j_1365_2265_2006_02669_x CEN2669 ark_67375_WNG_5J9MDJFS_7 |
| Genre | article |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 08P 0R~ 10A 1OB 1OC 29B 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K REN RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHHS ACCFJ ADZOD AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE ESX WRC WUP AAYXX CITATION IQODW |
| ID | FETCH-LOGICAL-c2969-76407d4ea0feaeea9ff33b149bd723388e1196f3307779dfdfee8ab6c1ca5363 |
| IEDL.DBID | DR2 |
| ISSN | 0300-0664 |
| IngestDate | Mon Jul 21 09:14:48 EDT 2025 Wed Oct 01 02:16:29 EDT 2025 Thu Apr 24 23:01:46 EDT 2025 Wed Jan 22 16:28:40 EST 2025 Sun Sep 21 06:18:05 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Human Oxidoreductases Striated muscle Enzyme Endocrinology 11β-Hydroxysteroid dehydrogenase |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2969-76407d4ea0feaeea9ff33b149bd723388e1196f3307779dfdfee8ab6c1ca5363 |
| Notes | ark:/67375/WNG-5J9MDJFS-7 ArticleID:CEN2669 istex:68DAD6E5884568141E49BDC06AE46767E1732C36 |
| PageCount | 6 |
| ParticipantIDs | pascalfrancis_primary_18294333 crossref_citationtrail_10_1111_j_1365_2265_2006_02669_x crossref_primary_10_1111_j_1365_2265_2006_02669_x wiley_primary_10_1111_j_1365_2265_2006_02669_x_CEN2669 istex_primary_ark_67375_WNG_5J9MDJFS_7 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2006 |
| PublicationDateYYYYMMDD | 2006-12-01 |
| PublicationDate_xml | – month: 12 year: 2006 text: December 2006 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford |
| PublicationTitle | Clinical endocrinology (Oxford) |
| PublicationYear | 2006 |
| Publisher | Blackwell Publishing Ltd Blackwell |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
| References | Tomlinson, J.W., Walker, E.A., Bujalska, I.J., Draper, N., Lavery, G.G., Cooper, M.S., Hewison, M. & Stewart, P.M. (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews, 25, 831-866. Levy, J.C., Matthews, D.R. & Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192. Glanemann, C., Loos, A., Gorret, N., Willis, L.B., O'Brien, X.M., Lessard, P.A. & Sinskey, A.J. (2003) Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Applied Microbiology and Biotechnology, 61, 61-68. Zierath, J.R. & Hawley, J.A. (2004) Skeletal muscle fiber type: influence on contractile and metabolic properties. Public Library of Science Biology, 2, e348. Gaster, M., Staehr, P., Beck-Nielsen, H., Schroder, H.D. & Handberg, A. (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes, 50, 1324-1329. Abe, T., Kearns, C.F. & Fukunaga, T. (2003) Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. British Journal of Sports Medicine, 37, 436-440. Albiston, A.L., Obeyesekere, V.R., Smith, R.E. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology, 105, R11-R17. Mabuchi, K. & Sreter, F.A. (1980) Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction. Muscle and Nerve, 3, 233-239. Pachucki, J., Ambroziak, M., Tanski, Z., Luczak, J., Nauman, J. & Nauman, A. (2001) Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation, 24, 253-261. Seckl, J.R. & Walker, B.R. (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-1376. Bujalska, I.J., Kumar, S. & Stewart, P.M. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet, 349, 1210-1213. Zierath, J.R., Krook, A. & Wallberg-Henriksson, H. (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia, 43, 821-835. Nair, S., Lee, Y.H., Lindsay, R.S., Walker, B.R., Tataranni, P.A., Bogardus, C., Baier, L.J. & Permana, P.A. (2004) 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia, 47, 1088-1095. Bujalska, I.J., Draper, N., Michailidou, Z., Tomlinson, J.W., White, P.C., Chapman, K.E., Walker, E.A. & Stewart, P.M. (2005) Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology, 34, 675-684. DeFronzo, R.A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren, J. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. Journal of Clinical Investigation, 76, 149-155. Abdallah, B.M., Beck-Nielsen, H. & Gaster, M. (2005) Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. European Journal of Clinical Investigation, 35, 627-634. Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. & White, P.C. (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. Journal of Biological Chemistry, 266, 16653-16658. Hickey, M.S., Carey, J.O., Azevedo, J.L., Houmard, J.A., Pories, W.J., Israel, R.G. & Dohm, G.L. (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. American Journal of Physiology, 268, E453-E457. Bujalska, I.J., Walker, E.A., Hewison, M. & Stewart, P.M. (2002) A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Journal of Clinical Endocrinology and Metabolism, 87, 1205-1210. Atanasov, A.G., Nashev, L.G., Schweizer, R.A., Frick, C. & Odermatt, A. (2004) Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters, 571, 129-133. Hammami, M.M. & Siiteri, P.K. (1991) Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. Journal of Clinical Endocrinology and Metabolism, 73, 326-334. Christopher, M., Hew, F.L., Oakley, M., Rantzau, C. & Alford, F. (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Journal of Clinical Endocrinology and Metabolism, 83, 1668-1681. Whorwood, C.B., Donovan, S.J., Wood, P.J. & Phillips, D.I. (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Journal of Clinical Endocrinology and Metabolism, 86, 2296-2308. Banhegyi, G., Benedetti, A., Fulceri, R. & Senesi, S. (2004) Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. Journal of Biological Chemistry, 279, 27017-27021. Schinner, S., Scherbaum, W.A., Bornstein, S.R. & Barthel, A. (2005) Molecular mechanisms of insulin resistance. Diabetes Medicine, 22, 674-682. Whorwood, C.B., Donovan, S.J., Flanagan, D., Phillips, D.I. & Byrne, C.D. (2002) Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes, 51, 1066-1075. Brereton, P.S., Van Driel, R.R., Suhaimi, F., Koyama, K., Dilley, R. & Krozowski, Z. (2001) Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology, 142, 1644-1651. Lindsay, R.S., Wake, D.J., Nair, S., Bunt, J., Livingstone, D.E., Permana, P.A., Tataranni, P.A. & Walker, B.R. (2003) Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism, 88, 2738-2744. 2001; 50 2001; 142 2002; 51 2004; 25 2000; 43 2004; 47 1991; 73 2003; 37 2004; 2 1998; 83 1998; 21 2001; 24 2005; 22 2001; 86 2004; 571 1994; 105 1997; 349 1991; 266 2004; 279 2002; 87 1980; 3 1995; 268 2003; 61 1985; 76 2005; 34 2005; 35 2003; 88 Zierath J.R. (e_1_2_6_12_2) 2004; 2 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_13_2 e_1_2_6_10_2 Tannin G.M. (e_1_2_6_2_2) 1991; 266 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_22_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 Seckl J.R. (e_1_2_6_3_2) 2001; 142 e_1_2_6_26_2 e_1_2_6_25_2 |
| References_xml | – reference: Whorwood, C.B., Donovan, S.J., Flanagan, D., Phillips, D.I. & Byrne, C.D. (2002) Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes, 51, 1066-1075. – reference: Levy, J.C., Matthews, D.R. & Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192. – reference: Bujalska, I.J., Draper, N., Michailidou, Z., Tomlinson, J.W., White, P.C., Chapman, K.E., Walker, E.A. & Stewart, P.M. (2005) Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology, 34, 675-684. – reference: Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. & White, P.C. (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. Journal of Biological Chemistry, 266, 16653-16658. – reference: Gaster, M., Staehr, P., Beck-Nielsen, H., Schroder, H.D. & Handberg, A. (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes, 50, 1324-1329. – reference: Mabuchi, K. & Sreter, F.A. (1980) Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction. Muscle and Nerve, 3, 233-239. – reference: Schinner, S., Scherbaum, W.A., Bornstein, S.R. & Barthel, A. (2005) Molecular mechanisms of insulin resistance. Diabetes Medicine, 22, 674-682. – reference: Hickey, M.S., Carey, J.O., Azevedo, J.L., Houmard, J.A., Pories, W.J., Israel, R.G. & Dohm, G.L. (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. American Journal of Physiology, 268, E453-E457. – reference: Bujalska, I.J., Walker, E.A., Hewison, M. & Stewart, P.M. (2002) A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Journal of Clinical Endocrinology and Metabolism, 87, 1205-1210. – reference: DeFronzo, R.A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren, J. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. Journal of Clinical Investigation, 76, 149-155. – reference: Tomlinson, J.W., Walker, E.A., Bujalska, I.J., Draper, N., Lavery, G.G., Cooper, M.S., Hewison, M. & Stewart, P.M. (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews, 25, 831-866. – reference: Brereton, P.S., Van Driel, R.R., Suhaimi, F., Koyama, K., Dilley, R. & Krozowski, Z. (2001) Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology, 142, 1644-1651. – reference: Pachucki, J., Ambroziak, M., Tanski, Z., Luczak, J., Nauman, J. & Nauman, A. (2001) Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation, 24, 253-261. – reference: Bujalska, I.J., Kumar, S. & Stewart, P.M. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet, 349, 1210-1213. – reference: Glanemann, C., Loos, A., Gorret, N., Willis, L.B., O'Brien, X.M., Lessard, P.A. & Sinskey, A.J. (2003) Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Applied Microbiology and Biotechnology, 61, 61-68. – reference: Christopher, M., Hew, F.L., Oakley, M., Rantzau, C. & Alford, F. (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Journal of Clinical Endocrinology and Metabolism, 83, 1668-1681. – reference: Lindsay, R.S., Wake, D.J., Nair, S., Bunt, J., Livingstone, D.E., Permana, P.A., Tataranni, P.A. & Walker, B.R. (2003) Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism, 88, 2738-2744. – reference: Zierath, J.R., Krook, A. & Wallberg-Henriksson, H. (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia, 43, 821-835. – reference: Hammami, M.M. & Siiteri, P.K. (1991) Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. Journal of Clinical Endocrinology and Metabolism, 73, 326-334. – reference: Whorwood, C.B., Donovan, S.J., Wood, P.J. & Phillips, D.I. (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Journal of Clinical Endocrinology and Metabolism, 86, 2296-2308. – reference: Banhegyi, G., Benedetti, A., Fulceri, R. & Senesi, S. (2004) Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. Journal of Biological Chemistry, 279, 27017-27021. – reference: Nair, S., Lee, Y.H., Lindsay, R.S., Walker, B.R., Tataranni, P.A., Bogardus, C., Baier, L.J. & Permana, P.A. (2004) 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia, 47, 1088-1095. – reference: Zierath, J.R. & Hawley, J.A. (2004) Skeletal muscle fiber type: influence on contractile and metabolic properties. Public Library of Science Biology, 2, e348. – reference: Atanasov, A.G., Nashev, L.G., Schweizer, R.A., Frick, C. & Odermatt, A. (2004) Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters, 571, 129-133. – reference: Seckl, J.R. & Walker, B.R. (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-1376. – reference: Abe, T., Kearns, C.F. & Fukunaga, T. (2003) Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. British Journal of Sports Medicine, 37, 436-440. – reference: Albiston, A.L., Obeyesekere, V.R., Smith, R.E. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology, 105, R11-R17. – reference: Abdallah, B.M., Beck-Nielsen, H. & Gaster, M. (2005) Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. European Journal of Clinical Investigation, 35, 627-634. – volume: 24 start-page: 253 year: 2001 end-page: 261 article-title: Type I 5′‐iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma publication-title: Journal of Endocrinological Investigation – volume: 142 start-page: 1644 year: 2001 end-page: 1651 article-title: Light and electron microscopy localization of the 11beta‐hydroxysteroid dehydrogenase type I enzyme in the rat publication-title: Endocrinology – volume: 21 start-page: 2191 year: 1998 end-page: 2192 article-title: Correct homeostasis model assessment (HOMA) evaluation uses the computer program publication-title: Diabetes Care – volume: 51 start-page: 1066 year: 2002 end-page: 1075 article-title: Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome publication-title: Diabetes – volume: 268 start-page: E453 year: 1995 end-page: E457 article-title: Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans publication-title: American Journal of Physiology – volume: 37 start-page: 436 year: 2003 end-page: 440 article-title: Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults publication-title: British Journal of Sports Medicine – volume: 279 start-page: 27017 year: 2004 end-page: 27021 article-title: Cooperativity between 11beta‐hydroxysteroid dehydrogenase type 1 and hexose‐6‐phosphate dehydrogenase in the lumen of the endoplasmic reticulum publication-title: Journal of Biological Chemistry – volume: 88 start-page: 2738 year: 2003 end-page: 2744 article-title: Subcutaneous adipose 11 beta‐hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 105 start-page: R11 year: 1994 end-page: R17 article-title: Cloning and tissue distribution of the human 11 beta‐hydroxysteroid dehydrogenase type 2 enzyme publication-title: Molecular and Cellular Endocrinology – volume: 25 start-page: 831 year: 2004 end-page: 866 article-title: 11beta‐hydroxysteroid dehydrogenase type 1: a tissue‐specific regulator of glucocorticoid response publication-title: Endocrine Reviews – volume: 50 start-page: 1324 year: 2001 end-page: 1329 article-title: GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? publication-title: Diabetes – volume: 86 start-page: 2296 year: 2001 end-page: 2308 article-title: Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta‐hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 34 start-page: 675 year: 2005 end-page: 684 article-title: Hexose‐6‐phosphate dehydrogenase confers oxo‐reductase activity upon 11 beta‐hydroxysteroid dehydrogenase type 1 publication-title: Journal of Molecular Endocrinology – volume: 349 start-page: 1210 year: 1997 end-page: 1213 article-title: Does central obesity reflect ‘Cushing's disease of the omentum’? publication-title: Lancet – volume: 2 start-page: e348 year: 2004 article-title: Skeletal muscle fiber type: influence on contractile and metabolic properties publication-title: Public Library of Science Biology – volume: 266 start-page: 16653 year: 1991 end-page: 16658 article-title: The human gene for 11 beta‐hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization publication-title: Journal of Biological Chemistry – volume: 35 start-page: 627 year: 2005 end-page: 634 article-title: Increased expression of 11beta‐hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes publication-title: European Journal of Clinical Investigation – volume: 3 start-page: 233 year: 1980 end-page: 239 article-title: Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction publication-title: Muscle and Nerve – volume: 83 start-page: 1668 year: 1998 end-page: 1681 article-title: Defects of insulin action and skeletal muscle glucose metabolism in growth hormone‐deficient adults persist after 24 months of recombinant human growth hormone therapy publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 87 start-page: 1205 year: 2002 end-page: 1210 article-title: A switch in dehydrogenase to reductase activity of 11 beta‐hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 142 start-page: 1371 year: 2001 end-page: 1376 article-title: – a tissue‐specific amplifier of glucocorticoid action publication-title: Endocrinology – volume: 76 start-page: 149 year: 1985 end-page: 155 article-title: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin‐dependent (type II) diabetes mellitus publication-title: Journal of Clinical Investigation – volume: 47 start-page: 1088 year: 2004 end-page: 1095 article-title: 11beta‐Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle publication-title: Diabetologia – volume: 73 start-page: 326 year: 1991 end-page: 334 article-title: Regulation of 11 beta‐hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 22 start-page: 674 year: 2005 end-page: 682 article-title: Molecular mechanisms of insulin resistance publication-title: Diabetes Medicine – volume: 61 start-page: 61 year: 2003 end-page: 68 article-title: Disparity between changes in mRNA abundance and enzyme activity in : implications for DNA microarray analysis publication-title: Applied Microbiology and Biotechnology – volume: 571 start-page: 129 year: 2004 end-page: 133 article-title: Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11beta‐hydroxysteroid dehydrogenase type 1 as an oxoreductase publication-title: FEBS Letters – volume: 43 start-page: 821 year: 2000 end-page: 835 article-title: Insulin action and insulin resistance in human skeletal muscle publication-title: Diabetologia – ident: e_1_2_6_28_2 doi: 10.1210/jcem-73-2-326 – volume: 266 start-page: 16653 year: 1991 ident: e_1_2_6_2_2 article-title: The human gene for 11 beta‐hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization publication-title: Journal of Biological Chemistry doi: 10.1016/S0021-9258(18)55351-5 – ident: e_1_2_6_21_2 doi: 10.1111/j.1365-2362.2005.01552.x – ident: e_1_2_6_11_2 doi: 10.1016/j.febslet.2004.06.065 – ident: e_1_2_6_15_2 doi: 10.2337/diacare.21.12.2191 – ident: e_1_2_6_27_2 doi: 10.1210/jc.87.3.1205 – volume: 2 start-page: e348 year: 2004 ident: e_1_2_6_12_2 article-title: Skeletal muscle fiber type: influence on contractile and metabolic properties publication-title: Public Library of Science Biology – ident: e_1_2_6_5_2 doi: 10.1016/S0140-6736(96)11222-8 – ident: e_1_2_6_13_2 doi: 10.1152/ajpendo.1995.268.3.E453 – ident: e_1_2_6_26_2 doi: 10.1007/BF03343855 – ident: e_1_2_6_25_2 doi: 10.1007/s00253-002-1191-5 – ident: e_1_2_6_4_2 doi: 10.1210/er.2003-0031 – ident: e_1_2_6_23_2 doi: 10.1677/jme.1.01718 – ident: e_1_2_6_6_2 doi: 10.1007/s001250051457 – ident: e_1_2_6_29_2 doi: 10.1172/JCI111938 – ident: e_1_2_6_16_2 doi: 10.1210/jc.83.5.1668 – ident: e_1_2_6_19_2 doi: 10.1002/mus.880030308 – ident: e_1_2_6_7_2 doi: 10.1111/j.1464-5491.2005.01566.x – ident: e_1_2_6_14_2 doi: 10.2337/diabetes.50.6.1324 – ident: e_1_2_6_24_2 doi: 10.1210/jc.2002-030017 – ident: e_1_2_6_10_2 doi: 10.1074/jbc.M404159200 – ident: e_1_2_6_20_2 doi: 10.1007/s00125-004-1407-6 – ident: e_1_2_6_17_2 doi: 10.1016/0303-7207(94)90176-7 – ident: e_1_2_6_18_2 doi: 10.1210/en.142.4.1644 – ident: e_1_2_6_22_2 doi: 10.1136/bjsm.37.5.436 – volume: 142 start-page: 1371 year: 2001 ident: e_1_2_6_3_2 article-title: – a tissue‐specific amplifier of glucocorticoid action publication-title: Endocrinology doi: 10.1210/endo.142.4.8114 – ident: e_1_2_6_9_2 doi: 10.1210/jc.86.5.2296 – ident: e_1_2_6_8_2 doi: 10.2337/diabetes.51.4.1066 |
| SSID | ssj0005807 |
| Score | 1.9580817 |
| Snippet | Summary
Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh... Objective No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human... |
| SourceID | pascalfrancis crossref wiley istex |
| SourceType | Index Database Enrichment Source Publisher |
| StartPage | 800 |
| SubjectTerms | Biological and medical sciences Endocrinopathies Fundamental and applied biological sciences. Psychology Medical sciences Vertebrates: endocrinology |
| Title | 11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle |
| URI | https://api.istex.fr/ark:/67375/WNG-5J9MDJFS-7/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2265.2006.02669.x |
| Volume | 65 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0300-0664 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1365-2265 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005807 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LThsx0EIgoV4Kpa0aXvIB9bZR9mWvjygkjSIlB0pVbpa9ttU0sCA2kQJfwzfwCXwA38SMdwks4oCq3lZezXo9nvHMeF6EHLDcYsyiCozK0iCJlQ2yPBZB5jJQ5YTW2md4j8Zs8CsZnqandfwT5sJU9SGWF27IGf68RgZXumwyuY_Qilha-xRA1og26pPwwltXx8-VpNI6czrGRGrGkmZQz5sfakiqNUT6AiMnVQnIc1XXi6ZG60VSf4NMnxZTRaJM2_OZbuc3r-o8_p_VbpKPteZKDytS-0RWbLFF1ke1b_4z-RuGD3d0cG3wd7D8wsXEUGP_4ABQKUhLive997chnZTULnwErjVUFQYHqmpQSDJn11T5U5hOCup7CNJyCtIRzAR6Pi9h8i_kpN876Q6CupNDkEeCiYCju9AkVnWcVdYq4VwcazDOtOERGMmZDeEkgLEO51wYZ5y1mdIsD3OVwmZ-JavFRWG_EZqk8B0HWifjYDgaBgYunCgOlBaHLvS8RfjTpsm8rnKOzTbO5AtrBzApEZPYg5NJj0m5aJFwCXlZVfp4B8x3TxdLAHU1xUg5nsrf4x8yHYrR0bD_U_IW2W8QzvMMWSSSOI5bhPntf_fUstsb49P2vwLukA9R3YSpE-6S1dnV3O6BgjXT-551HgFETRb0 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbhMxcIRaCbjwRk0pxQfEbaPsetdeH6u2IYQmBwiiN8u7tkVIukVNIqV8Dd_AJ_ABfBMz3m3KIg4V4rayZHs9nqfnBfBSlI5iFk1kTZ5FKTcuykuuotznqMqpoihChvdoLAYf0uFpdtq0A6JcmLo-xObBjSgj8GsicHqQblN5CNFKRNY4FVDYqC4qlNupQLOFNKR317WksiZ3mlMqtRBpO6znryu1ZNU2gX1NsZNmgeDzdd-Ltk4bhFL_PsyvjlPHosy6q2XRLb_-UenxP533AdxrlFd2UGPbQ7jlqkdwe9S45x_D5zj--Z0NLi39D1VgOJ9aZt0nGkBERYHJ6Mn3x7eYTRfMrUMQrrPMVJYG6oJQhDXzS2YCI2bTioU2gmwxQwGJlgI7Wy1w8ycw6R9PDgdR08whKhMlVCTJY2hTZ3reGeeM8p7zAu2zwsoE7eTcxcgMcKwnpVTWW-9cbgpRxqXJuOBPYas6r9wOsDTDdTwqnkKi7WgF2rjIVDzqLZ686GUH5NWt6bIpdE79Nub6N4MHIakJktSGU-gASb3uQLyZ-aUu9nGDOa8CYmwmmIsZBcvJTH8cv9bZUI2Ohv33WnZgv4U51zvkiUo55x0Q4f5vvLU-PB7T1-6_TnwBdwaT0Yk-eTN--wzuJk1Ppl68B1vLi5V7jvrWstgPdPQLzWQbFQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3bbtMw1EKbNPECjIEol80PiLdUTRzb8SNa13XdWqExxN4sJ7ZFacmmtZU6voZv4BP4gH3TznGybkE8TBNvkSXb8fG5-twIeS8KhzGLJrIm41HKjIuygqko8xmocirP85DhPRyJ_pd0cMpP63ZAmAtT1YdYPbghZQR-jQTuzq1vUnkI0UoEr50KIGxUGxTK9ZSrDOP7use3taR4nTvNMJVaiLQZ1vPPlRqyah3BvsTYSTMD8Pmq70VTpw1CqfeUTG-OU8WiTNqLed4ufv5V6fE_nfcZeVIrr_RjhW2b5JErn5ONYe2e3yLf4_jqN-1fWvwfrMBwNrbUum84AIgKApPik--fXzEdz6hbhiBcZ6kpLQ5UBaEQa6aX1ARGTMclDW0E6WwCAhIsBfpjMYPNX5CT3t7Jbj-qmzlERaKEiiR6DG3qTMc745xR3jOWg32WW5mAnZy5GJgBjHWklMp6653LTC6KuDCcCfaSrJVnpXtFaMphHQ-Kp5BgO1oBNi4wFQ96i0cvetEi8ubWdFEXOsd-G1N9x-ABSGqEJLbhFDpAUi9bJF7NPK-KfdxjzoeAGKsJ5mKCwXKS66-jfc0Hatgd9D5r2SLbDcy53SFLVMoYaxER7v_eW-vdvRF-vX7oxB2y8anb00cHo8M35HFSt2TqxG_J2vxi4d6BujXPtwMZXQNO6RqZ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=11%CE%B2+Hydroxysteroid+dehydrogenase+type%C2%A01+is+expressed+and+is+biologically+active+in+human+skeletal+muscle&rft.jtitle=Clinical+endocrinology+%28Oxford%29&rft.au=Jang%2C+Christina&rft.au=Obeyesekere%2C+Varuni+R.&rft.au=Dilley%2C+Rodney+J.&rft.au=Alford%2C+Frank+P.&rft.date=2006-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0300-0664&rft.eissn=1365-2265&rft.volume=65&rft.issue=6&rft.spage=800&rft.epage=805&rft_id=info:doi/10.1111%2Fj.1365-2265.2006.02669.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_5J9MDJFS_7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0664&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0664&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0664&client=summon |